Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation

被引:4
|
作者
Gong, Xiaoxian [1 ]
Chen, Hongfang [2 ]
Wang, Jianan [1 ]
Zhong, Wansi [1 ]
Chen, Luowei [1 ]
Yan, Shenqiang [1 ]
Lou, Min [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Jinhua Municipal Cent Hosp, Jinhua Hosp, Dept Neurol, Jinhua, Zhejiang, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
acute ischemic stroke; atrial fibrillation; anticoagulant therapy; cerebral infarction; undertreatment; ANTAGONIST ORAL ANTICOAGULANTS; ANTITHROMBOTIC TREATMENT; INTRACRANIAL HEMORRHAGE; RISK; PREVENTION; GUIDELINES; EFFICACY; UPDATE;
D O I
10.3389/fcvm.2022.841020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThis study aimed to investigate the prevalence and factors associated with the initiation of oral anticoagulation among patients with acute ischemic stroke (AIS) and concurrent atrial fibrillation (AF) at discharge in China. MethodsWe continuously included hospitalized patients with AIS with an AF diagnosis registered in the computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation (CASE II) from January 2016 to December 2020 and divided them into a and non-anticoagulant groups according to the medications at discharge. Binary logistic regression was used to determine the factors associated with the prescription of anticoagulants in patients with AF. ResultsA total of 16,162 patients were enrolled. The mean age was 77 +/- 9 years, 8,596 (53.2%) were males, and the median baseline National Institute of Health Stroke Scale score was 5 (2-12). Of the 14,838 patients without contraindications of antithrombotic therapy, 6,335 (42.7%) patients were initiated with anticoagulation treatment at discharge. Prior history of hemorrhagic stroke (OR 0.647, p < 0.001) and gastrointestinal bleeding (OR 0.607, p = 0.003) were associated with a lower rate of anticoagulation at discharge. Patients with any intracranial hemorrhage (OR 0.268, p < 0.001), gastrointestinal bleeding (OR 0.353, p < 0.001), or pneumonia during hospitalization (OR 0.601, p < 0.001) were less likely to receive anticoagulants at discharge. Among 7,807 patients with previously diagnosed AF and high risk of stroke (CHA(2)DS(2)-VASc >= 2), only 1,585 (20.3%) had been receiving anticoagulation treatment prior to the onset of stroke. However, the mean international normalized ratio (INR) was 1.5 on the first test during hospitalization in patients receiving warfarin. Patients complicated with a previous history of ischemic stroke/transient ischemic attack (TIA; OR 2.303, p < 0.001) and peripheral artery disease (OR 1.456, p = 0.003) were more common to start anticoagulants. ConclusionsLess than half of patients with AIS and concurrent AF initiated guideline-recommended oral anticoagulation at discharge, while only 20% of patients with previously diagnosed AF with a high risk of stroke had been using anticoagulants prior to the onset of stroke, which highlights a large care gap in hospitalized stroke patients and the importance of AF management.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
    Yan, Xiaodi
    Wang, Baoyan
    Xia, Peng
    Lan, Chen
    Wang, Qian
    Ge, Weihong
    Zhou, Yujie
    Jiang, Chenxiao
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [2] Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
    Seiffge, David J.
    De Marchis, Gian Marco
    Koga, Masatoshi
    Paciaroni, Maurizio
    Wilson, Duncan
    Cappellari, Manuel
    Macha, Kosmas
    Tsivgoulis, Georgios
    Ambler, Gareth
    Arihiro, Shoji
    Bonati, Leo H.
    Bonetti, Bruno
    Kallmuenzer, Bernd
    Muir, Keith W.
    Bovi, Paolo
    Gensicke, Henrik
    Inoue, Manabu
    Schwab, Stefan
    Yaghi, Shadi
    Brown, Martin M.
    Lyrer, Philippe
    Takagi, Masahito
    Acciarrese, Monica
    Jager, Hans Rolf
    Polymeris, Alexandros A.
    Toyoda, Kazunori
    Venti, Michele
    Traenka, Christopher
    Yamagami, Hiroshi
    Alberti, Andrea
    Yoshimura, Sohei
    Caso, Valeria
    Engelter, Stefan T.
    Werring, David J.
    ANNALS OF NEUROLOGY, 2020, : 677 - 687
  • [3] Anticoagulant Treatment in Patients with Atrial Fibrillation and Ischemic Stroke
    Frandsen, Nicole Scheldon Brunner
    Andersen, Andreas Dammann
    Ashournia, Hamoun
    Brandslund, Ivan
    Kjaersgaard, Jens Ole
    Vilholm, Ole Jakob
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (06): : 1120 - 1125
  • [4] Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack
    Patel, Priyesh A.
    Zhao, Xin
    Fonarow, Gregg C.
    Lytle, Barbara L.
    Smith, Eric E.
    Xian, Ying
    Bhatt, Deepak L.
    Peterson, Eric D.
    Schwamm, Lee H.
    Hernandez, Adrian F.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (04): : 383 - 392
  • [5] Effects of anticoagulant treatment on acute ischemic stroke severity and outcome in patients with atrial fibrillation
    Tziomalos, K.
    Bouziana, S. D.
    Spanou, M.
    Papadopoulou, M.
    Giampatzis, V.
    Dourliou, V.
    Kazantzidou, P.
    Kostaki, S.
    Savopoulos, C.
    Hatzitolios, A. I.
    CEREBROVASCULAR DISEASES, 2014, 37 : 55 - 55
  • [6] Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes
    Paciaroni, Maurizio
    Bandini, Fabio
    Agnelli, Giancarlo
    Tsivgoulis, Georgios
    Yaghi, Shadi
    Furie, Karen L.
    Tadi, Prasanna
    Becattini, Cecilia
    Zedde, Marialuisa
    Abdul-Rahim, Azmil H.
    Lees, Kennedy R.
    Alberti, Andrea
    Venti, Michele
    Acciarresi, Monica
    D'Amore, Cataldo
    Mosconi, Maria Giulia
    Cimini, Ludovica Anna
    Altavilla, Riccardo
    Volpi, Giacomo
    Bovi, Paolo
    Carletti, Monica
    Rigatelli, Alberto
    Cappellari, Manuel
    Putaala, Jukka
    Tomppo, Liisa
    Tatlisumak, Turgut
    Marcheselli, Simona
    Pezzini, Alessandro
    Poli, Loris
    Padovani, Alessandro
    Masotti, Luca
    Vannucchi, Vieri
    Sohn, Sung-Il
    Lorenzini, Gianni
    Tassi, Rossana
    Guideri, Francesca
    Acampa, Maurizio
    Martini, Giuseppe
    Ntaios, George
    Athanasakis, George
    Makaritsis, Konstantinos
    Karagkiozi, Efstathia
    Vadikolias, Konstantinos
    Liantinioti, Chrissoula
    Chondrogianni, Maria
    Mumoli, Nicola
    Consoli, Domenico
    Galati, Franco
    Sacco, Simona
    Carolei, Antonio
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (22):
  • [7] Limited Use of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation After Ischemic Stroke
    McGrath, Emer R.
    Go, Alan
    Chang Yuchiao
    Borowsky, Leila
    Fang, Margaret C.
    Reynolds, Kristi
    Singer, Daniel E.
    STROKE, 2016, 47
  • [8] Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation
    Kate, Mahesh
    Gioia, Laura
    Buck, Brian
    Sivakumar, Leka
    Jeerakathil, Thomas
    Shuaib, Ashfaq
    Butcher, Kenneth
    STROKE, 2015, 46 (09) : 2685 - 2687
  • [9] Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation
    McGrath, Emer R.
    Kapral, Moira K.
    Fang, Jiming
    Eikelboom, John W.
    Conghaile, Aengus O.
    Canavan, Michelle
    O'Donnell, Martin J.
    STROKE, 2014, 45 (12) : 3637 - +
  • [10] What Is the Best Anticoagulant Therapy in Acute-Phase Ischemic Stroke With Nonvalvular Atrial Fibrillation?
    Fujimoto, Shigeru
    CIRCULATION JOURNAL, 2022, 86 (06) : 964 - 965